Retrospective Study
Copyright ©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1441-1449
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1441
Table 3 Comparison of the treatment information, n (%)
Variable
Death group (n = 12)
Improved group (n = 60)
χ2
P value
ICUNo8 (66.7)59 (98.3)21.2780.001b
Arteriovenous catheterizationYes4 (33.3)1 (1.7)15.5180.000b
Tracheal intubationYes4 (33.3)1 (1.7)15.5180.000b
Catheterization cannulaYes4 (33.3)1 (1.7)15.5180.000b
No antibioticsYes12 (100)54 (90)1.3090.253
QuinolonesYes3 (25)14 (23.3)0.0150.901
CarbapenemsYes10 (83.3)25 (41.7)6.9500.008b
First and second generations of cephalosporinYes1 (8.3)11 (18.3)0.7200.396
Third-generation cephalosporinYes0 (0)10 (16.7)2.1340.144
Antibiotics with an enzyme inhibitorYes5 (41.7)22 (36.7)0.1070.744
VancomycinYes3 (25)5 (8.3)0.094